Challenges of clinical trial design when there is lack of clinical equipoise: use of a response-conditional crossover design
Authors:
Open Access
- 7 August 2011
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 259 (2) , 348-352
Abstract
Clinical equipoise is widely accepted as the basis of ethics in clinical research and requires investigators to be uncertain of the relative therapeutic merits of trial comparators. When clinical equipoise is in question, innovative trial designs are needed to reduce ethical tension while satisfying regulators’ requirements. We report a novel response-conditional crossover study design used in a Phase 3, randomized, double-blind, placebo-controlled clinical trial of intravenous 10% caprylate-chromatography purified immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. During the initial 24-week period, patients crossed over to the alternative treatment at the first sign of deterioration or if they failed to improve or were unable to maintain improvement at any time after 6 weeks. This trial design addressed concerns about lack of equipoise raised by physicians interested in trial participation and proved acceptable to regulatory authorities. The trial design may be applicable to other studies where clinical equipoise is in question.Keywords
This publication has 21 references indexed in Scilit:
- Clinical Equipoise and the Incoherence of Research EthicsThe Journal of Medicine and Philosophy: A Forum for Bioethics and Philosophy of Medicine, 2007
- So-Called "Clinical Equipoise" and the Argument from DesignThe Journal of Medicine and Philosophy: A Forum for Bioethics and Philosophy of Medicine, 2007
- Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathyJournal of the Peripheral Nervous System, 2003
- Loss of Phosphatase Activity in Myotubularin‐related Protein 2 is Associated with Charcot‐marie‐tooth Disease Type 4B1Journal of the Peripheral Nervous System, 2003
- Ethics of clinical trials from a bayesian and decision analytic perspective: whose equipoise is it anyway?BMJ, 2003
- Avoiding a Jekyll-And-Hyde Approach to the Ethics of Clinical Research and PracticeThe American Journal of Bioethics, 2002
- Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy2002
- Can unequal be more fair? Ethics, subject allocation, and randomised clinical trials.Journal of Medical Ethics, 1998
- Ethics and Statistics in Randomized Clinical TrialsStatistical Science, 1991
- Equipoise and the Ethics of Clinical ResearchNew England Journal of Medicine, 1987